Lupin (NSE:LUPIN) Pre-Tax Income : ₹24,223 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Lupin Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Lupin's pretax income for the three months ended in Mar. 2024 was ₹4,977 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ₹24,223 Mil. Lupin's pretax margin was 10.17%.

During the past 13 years, Lupin's highest Pretax Margin was 27.13%. The lowest was -8.47%. And the median was 10.54%.

Lupin Pre-Tax Income Historical Data

The historical data trend for Lupin's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin Pre-Tax Income Chart

Lupin Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Pre-Tax Income

Get a 7-Day Free Trial

7,572.30

16,764.50

-13,722.10

7,164.90

24,222.70

Lupin Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															2,585.00	5,587.90	6,296.70	7,361.00	4,977.10

Competitive Comparison of Lupin's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Lupin's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lupin's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lupin's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Lupin's Pre-Tax Income falls into.

Lupin Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Lupin's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	26032	+	0	+	-3116.1	+	0	+	1306.8
	=	24,223

Lupin's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	5396.6	+	0	+	-712.9	+	0	+	293.4
	=	4,977

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹24,223 Mil.

Lupin (NSE:LUPIN) Pre-Tax Income Explanation

Lupin's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	4977.1	/	48951.1
	=	10.17%

During the past 13 years, Lupin's highest Pretax Margin was 27.13%. The lowest was -8.47%. And the median was 10.54%.

Lupin Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Lupin's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Lupin (NSE:LUPIN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » Pre-Tax Income

Traded in Other Exchanges

500257:India

Address

Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400 055

Website

https://www.lupin.com

Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The operations of the company are limited to one segment, namely pharmaceuticals and related products. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Lupin (NSE:LUPIN) Headlines

No Headlines